Assenagon Asset Management S.A. raised its position in Welltower Inc. (NYSE:WELL - Free Report) by 8.0% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 22,754 shares of the real estate investment trust's stock after acquiring an additional 1,690 shares during the period. Assenagon Asset Management S.A.'s holdings in Welltower were worth $3,498,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Nuveen LLC bought a new stake in shares of Welltower during the 1st quarter worth approximately $762,204,000. Price T Rowe Associates Inc. MD raised its stake in shares of Welltower by 41.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,923,852 shares of the real estate investment trust's stock worth $1,367,226,000 after purchasing an additional 2,622,384 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Welltower by 14.0% during the 1st quarter. Wellington Management Group LLP now owns 21,289,684 shares of the real estate investment trust's stock worth $3,261,792,000 after purchasing an additional 2,614,562 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Welltower by 17,343.3% during the 1st quarter. GAMMA Investing LLC now owns 1,738,052 shares of the real estate investment trust's stock worth $266,287,000 after purchasing an additional 1,728,088 shares in the last quarter. Finally, Cbre Investment Management Listed Real Assets LLC raised its stake in shares of Welltower by 55.6% during the 1st quarter. Cbre Investment Management Listed Real Assets LLC now owns 3,013,247 shares of the real estate investment trust's stock worth $461,660,000 after purchasing an additional 1,076,293 shares in the last quarter. Institutional investors own 94.80% of the company's stock.
Welltower Stock Down 0.9%
WELL stock opened at $170.94 on Thursday. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.19 and a quick ratio of 4.19. The stock has a market capitalization of $114.33 billion, a price-to-earnings ratio of 96.57, a PEG ratio of 1.94 and a beta of 0.93. The business's fifty day moving average price is $165.89 and its two-hundred day moving average price is $155.29. Welltower Inc. has a fifty-two week low of $122.34 and a fifty-two week high of $173.22.
Welltower (NYSE:WELL - Get Free Report) last posted its quarterly earnings data on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.06. The firm had revenue of $2.55 billion for the quarter, compared to analysts' expectations of $2.49 billion. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The company's quarterly revenue was up 39.6% compared to the same quarter last year. During the same quarter last year, the business earned $1.05 EPS. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. On average, equities analysts anticipate that Welltower Inc. will post 4.88 earnings per share for the current year.
Welltower Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 21st. Shareholders of record on Tuesday, August 12th were given a dividend of $0.74 per share. This represents a $2.96 annualized dividend and a yield of 1.7%. The ex-dividend date was Tuesday, August 12th. This is a positive change from Welltower's previous quarterly dividend of $0.67. Welltower's dividend payout ratio (DPR) is 167.23%.
Insiders Place Their Bets
In other news, Director Andrew Gundlach acquired 20,000 shares of the stock in a transaction on Monday, June 30th. The shares were purchased at an average price of $151.46 per share, for a total transaction of $3,029,200.00. Following the transaction, the director directly owned 20,000 shares of the company's stock, valued at approximately $3,029,200. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.21% of the stock is owned by insiders.
Analysts Set New Price Targets
WELL has been the topic of a number of analyst reports. Scotiabank upped their price objective on Welltower from $172.00 to $181.00 and gave the stock an "outperform" rating in a research note on Thursday, August 28th. KeyCorp upped their price objective on Welltower from $150.00 to $200.00 and gave the stock an "overweight" rating in a research note on Tuesday. UBS Group initiated coverage on Welltower in a research note on Friday, September 19th. They issued a "buy" rating and a $195.00 price target on the stock. Evercore ISI increased their price target on Welltower from $175.00 to $183.00 and gave the company an "in-line" rating in a research note on Monday, September 15th. Finally, Raymond James Financial restated a "strong-buy" rating on shares of Welltower in a research note on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $179.42.
Get Our Latest Analysis on Welltower
Welltower Company Profile
(
Free Report)
Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.